Kenneth A Earle

Summary

Affiliation: St George's
Country: UK

Publications

  1. ncbi Circulating cholesterol as a modulator of risk for renal injury in patients with type 2 diabetes
    Kenneth A Earle
    Royal Free and University College Medical School, Department of Medicine, Whittington Hospital, London, UK
    Diabetes Res Clin Pract 79:68-73. 2008
  2. ncbi Nitric oxide bioavailability and its potential relevance to the variation in susceptibility to the renal and vascular complications in patients with type 2 diabetes
    Kenneth A Earle
    University College London Medical School, Whittington Hospital, London, UK
    Diabetes Care 32:138-40. 2009
  3. ncbi Mobile telemonitoring for achieving tighter targets of blood pressure control in patients with complicated diabetes: a pilot study
    Kenneth A Earle
    Thomas Addison Unit, St George s Hospital NHS Trust, London, United Kingdom
    Diabetes Technol Ther 12:575-9. 2010
  4. ncbi Circulating vitamin E, transforming growth factor beta1, and the association with renal disease susceptibility in two racial groups with type 2 diabetes
    Karima Zitouni
    Department of Medicine, Royal Free and University College Medical School, Whittington Hospital, London, United Kingdom
    Kidney Int 67:1993-8. 2005
  5. ncbi Evaluation of a mobile phone telemonitoring system for glycaemic control in patients with diabetes
    Robert S H Istepanian
    Mobile Information and Network Technologies Centre, Kingston University, London, UK
    J Telemed Telecare 15:125-8. 2009
  6. ncbi Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes
    Elizabeth A Denver
    Royal Free and University College London Medical School, Whittington Hospital, London, UK
    Diabetes Care 26:2256-60. 2003
  7. ncbi Race-specific differences in antioxidant enzyme activity in patients with type 2 diabetes: a potential association with the risk of developing nephropathy
    Karima Zitouni
    Department of Cellular and Molecular Medicine, St. George's Hospital NHS Trust, Thomas Addison Diabetes Centre, London SW17 ORE, UK
    Diabetes Care 28:1698-703. 2005

Collaborators

Detail Information

Publications7

  1. ncbi Circulating cholesterol as a modulator of risk for renal injury in patients with type 2 diabetes
    Kenneth A Earle
    Royal Free and University College Medical School, Department of Medicine, Whittington Hospital, London, UK
    Diabetes Res Clin Pract 79:68-73. 2008
    ..Blood pressure correlated with cholesterol concentrations in patients of African origin. Specific cholesterol lowering strategies may benefit certain patients groups at high risk of renal disease...
  2. ncbi Nitric oxide bioavailability and its potential relevance to the variation in susceptibility to the renal and vascular complications in patients with type 2 diabetes
    Kenneth A Earle
    University College London Medical School, Whittington Hospital, London, UK
    Diabetes Care 32:138-40. 2009
    ..We compared the renal and systemic vascular (renovascular) response to a reduction of bioavailable nitric oxide (NO) in type 2 diabetic patients without nephropathy and of African and Caucasian heritage...
  3. ncbi Mobile telemonitoring for achieving tighter targets of blood pressure control in patients with complicated diabetes: a pilot study
    Kenneth A Earle
    Thomas Addison Unit, St George s Hospital NHS Trust, London, United Kingdom
    Diabetes Technol Ther 12:575-9. 2010
    ..Hypertension is a major risk factor for the long-term complications of diabetes. Mobile, self-measurement of blood pressure is emerging as a method to manage blood pressure in general, but its impact in patients with diabetes is unclear...
  4. ncbi Circulating vitamin E, transforming growth factor beta1, and the association with renal disease susceptibility in two racial groups with type 2 diabetes
    Karima Zitouni
    Department of Medicine, Royal Free and University College Medical School, Whittington Hospital, London, United Kingdom
    Kidney Int 67:1993-8. 2005
    ....
  5. ncbi Evaluation of a mobile phone telemonitoring system for glycaemic control in patients with diabetes
    Robert S H Istepanian
    Mobile Information and Network Technologies Centre, Kingston University, London, UK
    J Telemed Telecare 15:125-8. 2009
    ..In a sub-group analysis of the patients who completed the study, the telemonitoring group had a lower HbA(1c) than those in the control group: 7.76% and 8.40%, respectively (P = 0.06)...
  6. ncbi Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes
    Elizabeth A Denver
    Royal Free and University College London Medical School, Whittington Hospital, London, UK
    Diabetes Care 26:2256-60. 2003
    ..A target systolic BP <140 mmHg is more readily achieved and may be associated with significant reductions in 10-year cardiovascular disease risk scores...
  7. ncbi Race-specific differences in antioxidant enzyme activity in patients with type 2 diabetes: a potential association with the risk of developing nephropathy
    Karima Zitouni
    Department of Cellular and Molecular Medicine, St. George's Hospital NHS Trust, Thomas Addison Diabetes Centre, London SW17 ORE, UK
    Diabetes Care 28:1698-703. 2005
    ..CONCLUSIONS: SOD and GPx enzyme activities vary according to race and could account for differences in lipid hydroperoxide. In patients of African origin, susceptibility to renal disease may be associated with lowered GPx activity...